The story of how Novo Nordisk will lose billions because it didn’t pay a couple of hundred dollars

marketwatch.com/story/the-story-of-how-novo-nordisk-will-lose-billions-because-it-didnt-pay-a-couple-of-hundred-dollars-bcef7c01

Novo Nordisk’s annual report contains an interesting footnote on its key drug, Ozempic, which last year accounted for $19 billion of sales worldwide.

This story appeared on marketwatch.com, 2025-06-16 08:24:00.
The Entire Business World on a Single Page. Free to Use →